Literature DB >> 11119198

Diclofenac and flurbiprofen with or without clonidine for postoperative analgesia in children undergoing elective ophthalmological surgery.

K Nishina1, K Mikawa, M Shiga, Y Takao, N Maekawa, H Obara.   

Abstract

We conducted a prospective, randomized study to compare the efficacy of preoperative diclofenac, flurbiprofen, and clonidine, given alone, as well as the combination of diclofenac and clonidine, and flurbiprofen and clonidine in controlling postoperative pain in 125 children. The patients (ASA I, 2-12 years) undergoing elective ophthalmological surgery were allocated to one of five groups: rectal diclofenac 2 mg.kg(-1) following oral placebo premedication, i. v. flurbiprofen 1 mg.kg(-1) following placebo premedication, oral clonidine premedication, rectal diclofenac 2 mg.kg(-1) following clonidine, and i.v. flurbiprofen 1 mg.kg(-1) following clonidine. The children received clonidine (4 microg.kg(-1)) or placebo 105 min before anaesthesia. Diclofenac or flurbiprofen was given immediately after induction of anaesthesia. Anaesthesia was induced and maintained with sevoflurane and nitrous oxide in oxygen. Postoperative pain was assessed by a blinded observer using a modified objective pain scale (OPS). No opioids were administered throughout the study. Rectal diclofenac 2 mg.kg(-1) i.v. flurbiprofen 1 mg.kg(-1), oral clonidine 4 microg.kg(-1) provided similar OPS scores and requirement for supplementary analgesics during 12 h after surgery. Combination of oral clonidine and one of these nonsteroidal analgesics minimized postoperative pain. Our findings suggest that this combined regimen may be a promising prophylactic approach to postoperative pain control in children undergoing ophthalmological surgery.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11119198     DOI: 10.1111/j.1460-9592.2000.00589.x

Source DB:  PubMed          Journal:  Paediatr Anaesth        ISSN: 1155-5645            Impact factor:   2.556


  8 in total

Review 1.  WITHDRAWN: Diclofenac for acute pain in children.

Authors:  Joseph F Standing; Imogen Savage; Deborah Pritchard; Marina Waddington
Journal:  Cochrane Database Syst Rev       Date:  2015-07-02

2.  Plasma and cerebrospinal fluid pharmacokinetics of flurbiprofen in children.

Authors:  Elina Kumpulainen; Pyry Välitalo; Merja Kokki; Marko Lehtonen; Andrew Hooker; Veli-Pekka Ranta; Hannu Kokki
Journal:  Br J Clin Pharmacol       Date:  2010-10       Impact factor: 4.335

3.  Clonidine in paediatrics - a review.

Authors:  Sujatha Basker; Georgene Singh; Rebecca Jacob
Journal:  Indian J Anaesth       Date:  2009-06

Review 4.  Nonsteroidal anti-inflammatory drugs for postoperative pain: a focus on children.

Authors:  Hannu Kokki
Journal:  Paediatr Drugs       Date:  2003       Impact factor: 3.022

5.  A systematic review of the effects of sedatives and anesthetics in patients with obstructive sleep apnea.

Authors:  Saravanan Ankichetty; Jean Wong; Frances Chung
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2011-10

Review 6.  Current State of Analgesia and Sedation in the Pediatric Intensive Care Unit.

Authors:  Chinyere Egbuta; Keira P Mason
Journal:  J Clin Med       Date:  2021-04-23       Impact factor: 4.241

7.  Postoperative short-term use of the nonsteroidal anti-inflammatory drug flurbiprofen did not increase the anastomotic leakage rate in patients undergoing elective gastrointestinal surgery-a retrospective cohort study.

Authors:  Huang Nie; Yiming Hao; Xiangying Feng; Lina Ma; Yumei Ma; Zhen Zhang; Xi'an Han; Jian Zhong Zhang; Ping Zhang; Qingchuan Zhao; Hailong Dong
Journal:  Perioper Med (Lond)       Date:  2022-08-19

8.  Effectiveness of analgesia with hydromorphone hydrochloride for postoperative pain following surgical repair of structural congenital malformations in children: a randomized controlled trial.

Authors:  Yongying Pan; Yimin Wang; Dongxu Lie; Di Liu; Xi Chen; Zeyan Wu; Liumei Chen; Huaizhen Wang; Liangming Peng; Huiying Liang; Xingrong Song; Baisong Zhao
Journal:  BMC Anesthesiol       Date:  2021-07-16       Impact factor: 2.217

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.